Somatic copy number changes in DPYD are associated with lower risk of recurrence in triple-negative breast cancers

BACKGROUND: Genomic rearrangements at the fragile site FRA1E may disrupt the dihydropyrimidine dehydrogenase gene (DPYD) which is involved in 5-fluorouracil (5-FU) catabolism. In triple-negative breast cancer (TNBC), a subtype of breast cancer frequently deficient in DNA repair, we have investigated...

Descripción completa

Detalles Bibliográficos
Autores principales: Gross, E, Meul, C, Raab, S, Propping, C, Avril, S, Aubele, M, Gkazepis, A, Schuster, T, Grebenchtchikov, N, Schmitt, M, Kiechle, M, Meijer, J, Vijzelaar, R, Meindl, A, van Kuilenburg, A B P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3817342/
https://www.ncbi.nlm.nih.gov/pubmed/24104963
http://dx.doi.org/10.1038/bjc.2013.621

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3817342/
https://www.ncbi.nlm.nih.gov/pubmed/24104963
http://dx.doi.org/10.1038/bjc.2013.621

Ejemplares similares